A Study in the Treatment of Osteoarthritis Knee Pain

Osteoarthritis Knee Pain Clinical Trial

Official title:
A Phase 2 Study of the Effects of LY545694, an iGluR5 Antagonist, in the Treatment of Subjects With Osteoarthritis Knee Pain

Status Completed

Clinical Trial Summary

To gather data on whether a new drug for osteoarthritis knee pain will be safe and have an effect on pain levels.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00790790
Study type	Interventional
Source	Eli Lilly and Company
Contact
Status	Completed
Phase	Phase 2
Start date	November 2008
Completion date	January 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01018680` - A Study Comparing Duloxetine Versus Placebo in Patients Taking a Nonsteroidal Anti-inflammatory Drug (NSAID) for Knee Pain Due to Osteoarthritis	Phase 3
Completed	`NCT00408421` - Duloxetine Versus Placebo for Osteoarthritis Knee Pain	Phase 3
Completed	`NCT00945945` - A Study of Duloxetine in Patients With Osteoarthritis Knee Pain	Phase 3
Completed	`NCT03434197` - Safety and Efficacy of SFPP in Knee Osteoarthritis	Phase 3
Completed	`NCT00433290` - Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain	Phase 3